Suppr超能文献

新型 N,N'-二取代脲和硫脲衍生物的合成及生物评价作为潜在的抗黑色素瘤剂。

Synthesis and biological evaluation of novel N, N'-disubstituted urea and thiourea derivatives as potential anti-melanoma agents.

机构信息

State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, PR China.

出版信息

J Enzyme Inhib Med Chem. 2012 Oct;27(5):708-14. doi: 10.3109/14756366.2011.608665. Epub 2011 Oct 10.

Abstract

Two series of urea and thiourea derivatives (1a-11a, 1b-11b) have been synthesized; all the 22 compounds were reported for the first time. Their anti-proliferative activities against the melanoma cell line B16-F10 were evaluated. Among the compounds tested, compound 6b exhibited the most potent activity in melanoma cells growth inhibition (IC(50) = 0.33 μM). The bioassay tests showed that anti-proliferative activities of these novel compounds were possibly caused by inhibition of ERK1/2 phosphorylation level. Therefore, compound 6b can be a potential anti-melanoma agent and an inhibitor of ERK1/2 phosphorylation deserving further research.

摘要

已经合成了两个系列的脲和硫脲衍生物(1a-11a,1b-11b);所有 22 种化合物均为首次报道。评估了它们对黑色素瘤细胞系 B16-F10 的抗增殖活性。在所测试的化合物中,化合物 6b 对黑色素瘤细胞生长抑制的活性最强(IC(50)=0.33 μM)。生物测定试验表明,这些新型化合物的抗增殖活性可能是通过抑制 ERK1/2 磷酸化水平引起的。因此,化合物 6b 可能是一种潜在的抗黑色素瘤药物和 ERK1/2 磷酸化抑制剂,值得进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验